Strategic expansion Irwin Naturals is expanding into cannabis and mental health psychedelics, presenting opportunities to partner with retailers and distributors in adjacent wellness and alternative medicine categories to cross-sell and broaden market reach.

Public market presence As a public company on the Canadian Securities Exchange, Irwin Naturals may be open to co-branding, joint ventures, or investment-oriented partnerships that leverage public visibility and growth trajectory.

Omni-channel reach With products sold in over 100,000 doors including major retailers and strong online presence, there is a chance to optimize channel-specific promotions, private label opportunities, and category management programs.

Acquisition momentum Recent acquisitions in ketamine media and related wellness assets indicate a consolidation strategy; sales discussions could target integration opportunities, bundled offerings, or enterprise licensing across expanded product lines.

Scale-ready partnerships Revenue scale and manufacturing focus in nutraceuticals suggest readiness for co-manufacturing, contract development, and white-label programs with retailers and wellness brands seeking proven soft-gel or plant-based formulations.